approved and emerging therapies for mucopolysaccharidoses (mps)
Published 5 years ago • 583 plays • Length 6:14Download video MP4
Download video MP3
Similar videos
-
5:33
mucopolysaccharidosis type i: overview, diagnosis challenges, treatments, and emerging therapies
-
11:46
mucopolysaccharidoses and mucolipidoses explained
-
5:10
current treatment options for hurler syndrome (mucopolysaccharidosis type i or mps i)
-
2:44
overview of mucopolysaccharidosis type i (mps i)
-
3:34
gene therapy for mps
-
3:24
mucopolysaccharidosis conditions explained
-
9:15
gene therapy (rgx-111) to treat mucopolysaccharidosis type i (mps i)
-
2:19
phase 1/2 study evaluating sobi003 for treatment of mucopolysaccharidosis type iiia (mps iiia)
-
2:47
mucopolysaccharidoses: current therapies offer hope, but more effective treatments are needed
-
1:42
efficacy and safety of pabinafusp-alfa in mps-ii (hunter syndrome)
-
0:42
new cme program focused on mps ii (hunter syndrome)
-
12:14
overview of the mucopolysaccharidoses
-
3:30
common early features of mps
-
3:26
mucopolysaccharidosis type vii (mps vii or sly syndrome)
-
5:10
mucopolysaccharidosis type vi (mps vi or maroteaux-lamy syndrome)
-
31:17
webinar: covid-19 and mps patients
-
2:22
approved and emerging antibody-based therapies in myeloma
-
4:52
mucopolysaccharidosis type i (mps i or hurler syndrome)
-
47:51
identification and development of a small molecule therapy for mucopolysaccharidosis i